Genetic testing can identify individuals at increased risk for certain cancers by detecting specific gene mutations. This information is valuable for:
1. Risk assessment: Identifying individuals who may benefit from increased surveillance or preventive measures. 2. Personalized treatment: Tailoring therapies based on the genetic profile of the tumor. For instance, tumors with EGFR mutations may respond well to tyrosine kinase inhibitors. 3. Family planning: Providing information to family members about their own cancer risks.